Current Report Filing (8-k)
February 10 2017 - 09:59AM
Edgar (US Regulatory)
United
States
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 10, 2017
CHINA
JO-JO DRUGSTORES, INC.
(Exact
name of Registrant as specified in charter)
Nevada
|
|
001-34711
|
|
98-0557852
|
(State
or other jurisdiction
of Incorporation)
|
|
(Commission
File No.)
|
|
(IRS
Employer
Identification No.)
|
1st
Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road
Hangzhou,
Zhejiang Province, People’s Republic of China
(Address
of principal executive offices) (Zip Code)
Registrant's
telephone number, including area code:
+86 (571) 88077078
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item
2.02. Results of Operations and Financial Condition.
On
February 10, 2017, China Jo-Jo Drugstores, Inc. (the “Company”) issued a press release announcing certain financial
results for the second quarter ended December 31, 2016. A copy of the press release is attached hereto as Exhibit 99.1.
This
information under this Item 2.02 and the press release attached to this Form 8-K as Exhibit 99.1 shall be deemed to be “furnished”
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed incorporated by
reference in any filing under the Exchange Act or the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits.
The
following is filed as an exhibit to this report:
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release, dated February 10, 2016.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CHINA
JO-JO DRUGSTORES, INC.
|
|
|
|
Date:
February 10, 2017
|
By:
|
/s/
Ming Zhao
|
|
Name:
|
Ming
Zhao
|
|
Title:
|
Chief
Financial Officer
|
3
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Feb 2024 to Mar 2024
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Mar 2023 to Mar 2024